S. Fan, M. L. Smith, D. J. Rivet, II, D. Duba, Q. Zhan, K. W. Kohn, A. J. Fornace and P. M. O'Connor, Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res. 55, 1649-1654 (1995).
H. J. Fingert, A. T. Pu, Z. Chen, P. B. Googe, M. C. Alley and A. B. Pardee, In vivo and in vitro enhanced antitumor effects by pentoxifylline in human cancer cells treated with thiotepa, Cancer Res. 48, 4375-4381 (1988).
K. J. Russell, L. W. Wiens, W. Demers, D. A. Galloway, S. E. Plon and M. Groudine, Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 check-point-competent cells. Cancer Res. 55, 1639-1642 (1995).
J. H. Hong, C. S. Chiang, I. L. Campbell, J. R. Sun, H. R. Withers and W. H. McBride, Induction of acute phase gene expression by brain irradiation. Int. J. Radiat. Oncol. Biol. Phys. 33, 619-626 (1995).
E. J. Bernhard, W. G. McKenna and R. J. Muschel, Cyclin expression and G2-phase delay after irradiation. Radiat. Res. 138 (Suppl.), S64-S67 (1994).
D. J. Honess, I. J. Dennis and N. M. Bleehen, Pentoxifylline: Its pharmacokinetics and ability to improve tumour perfusion and radiosensitivity in mice. Radiother. Oncol. 28, 208-218 (1993).
S. N. Powell, J. S. DeFrank, P. Connell, M. Eogan, F. Reffer, D. Dombkowski, W. Tang and S. Friend, Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res. 55, 1643-1648 (1995).
I. Lee, J. H. Kim, S. H. Levitt and C. W. Song, Increases in tumor response by pentoxifylline alone or in combination with nicotinamide. Int. J. Radiat. Oncol. Biol. Phys. 22, 425-429 (1992).
P. W. Sperduto, C. W. Song and S. H. Levitt, The in vitro radiosensitization of human glioblastoma with pentoxifylline. Am. J. Clin. Oncol. 16, 407-411 (1993).
S. H. Kim, M. S. Khil, S. Ryu and J. H. Kim, Enhancement of radiation response on human carcinoma cells in culture by pentoxifylline. Int. J. Radiat. Oncol. Biol. Phys. 25, 61-65 (1992).
C. W. Song, T. Hasegawa, H. C. Kwon, J. C. Lyons and S. H. Levitt, Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline. Radiat. Res. 130, 205-210 (1992).
K. J. Russell, L. W. Wiens, W. Demers, D. A. Galloway, T. Le, G. C. Rice, J. A. Bianco, J. W. Singer and M. Groudine, Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines. Int. J. Radiat. Oncol. Biol. Phys. 36, 1099-1106 (1996).
W. J. Koh, K. J. Stelzer, L. M. Peterson, B. L. Staker, W. F. Ward, K. J. Russell and T. W. Griffin, Effect of pentoxifylline on radiation-induced lung and skin toxicity in rats. Int. J. Radiat. Oncol. Biol. Phys. 31, 71-77 (1995).
I. Lee, Y. Boucher, T. J. Demhartner and R. K. Jain, Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline. Br. J. Cancer 69, 492-496 (1994).
M. Hollstein, D. Sidransky, B. Vogelstein and C. C. Harris, p53 mutations in human cancers. Science 253, 49-53 (1991).
K. Milde-Langosch, K. Albrecht, S. Joram, H. Schlechte, M. Giessing and T. Löning, Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int. J. Cancer 63, 639-645 (1995).
S. L. Yao, A. J. Akhtar, K. A. McKenna, G. C. Bedi, D. Sidransky, M. Mabry, R. Ravi, M. I. Collector, R. J. Jones, S. J. Sharkis, E. J. Fuchs and A. Bedi, Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nat. Med. 2, 1140-1143 (1996).
E. J. Bernhard, R. J. Muschel, V. J. Bakanauskas and W. G. McKenna, Reducing the radiation-induced G2 delay causes HeLa cells to undergo apoptosis instead of mitotic death. Int. J. Radiat. Biol. 69, 575-584 (1996).
J. S. Wang, G. Ara, S. R. Keyes, R. Herbst, N. Coleman and B. A. Teicher, Lisofylline as a modifier of radiation therapy. Oncol. Res. 12, 513-518 (1996).
C. Y. Li, H. Nagasawa, W. K. Dahlberg and J. B. Little, Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. Oncogene 11, 1885-1892 (1995).
K. Butz, L. Shahabeddin, C. Geisen, D. Spitkovsky, A. Ullmann and F. Hoppe-Seyler, Functional p53 protein in human papilloma virus-positive cancer cells. Oncogene 10, 927-936 (1995).
T. D. Kessis, R. J. Slebos, W. G. Nelson, M. B. Kastan, B. S. Plunkett, S. M. Han, A. T. Lorincz, L. Hedrick and K. R. Cho, Human papilloma virus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 90, 3988-3992 (1993).
R. Villa, N. Zaffaroni, A. Bearzatto, A. Costa, A. Sichirollo and R. Silvestrini, Effect of ionizing radiation on cell-cycle progression and cyclin B1 expression in human melanoma cells. Int. J. Cancer 66, 104-109 (1996).
M. F. M. A. Smeets, E. H. M. Mooren and A. C. Begg, The effect of radiation on G2 blocks, cyclin B expression and cdc2 expression in human squamous carcinoma cell lines with different radiosensitivities. Radiother. Oncol. 33, 217-227 (1994).
J. Hain, N. E. A. Crompton, W. Burkart and R. Jaussi, Caffeine release of radiation induced S and G2 phase arrest in V79 hamster cells: Increase of histone messenger RNA levels and p34cdc2 activation. Cancer Res. 53, 1507-1510 (1993).
R. B. Lock and W. E. Ross, Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells. Cancer Res. 50, 3761-3766 (1990).
L. H. Hartwell and T. A. Weinert, Checkpoints: Controls that ensure the order of cell cycle events. Science 246, 629-634 (1989).
L. H. Hartwell and M. B. Kastan, Cell cycle control and cancer. Science 266, 1821-1828 (1994).
Y. Wang and G. Iliakis, Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc. Cancer Res. 52, 508-514 (1992).
H. M. Warenius, M. D. Jones and C. C. M. Thompson, Exit from G2 phase after 2 Gy gamma irradiation is faster in radiosensitive human cells with high expression of RAF1 proto-oncogene. Radiat. Res. 146, 485-493 (1996).
W. G. McKenna, M. C. Weiss, B. Endlich, C. C. Ling, V. J. Bakanaustas, M. L. Kelsten and R. J. Muschel, Synergistic effect of the v-myc oncogene with H-ras on radioresistance. Cancer Res. 50, 97-102 (1990).
J. L. Schwartz, J. Cowan, D. J. Grdina and R. R. Weichselbaum, Attenuation of G2-phase cell cycle checkpoint control is associated with increased frequencies of unrejoined chromosome breaks in human tumor cells. Radiat. Res. 146, 139-143 (1996).
H. Nagasawa, P. Keng, R. Harley, W. Dahlberg and J. B. Little, Relationship between γ-ray-induced G2/M delay and cellular radiosensitivity. Int. J. Radiat. Biol. 66, 373-379 (1994).
M. F. M. A. Smeets, E. H. M. Mooren, A. H. A. Abdel-Wahab, H. Bartelink and A. C. Begg, Differential repair of radiation-induced DNA damage in cells of human squamous cell carcinoma and the effect of caffeine and cysteamine on induction and repair of DNA double-strand breaks. Radiat. Res. 140, 153-160 (1994).
S. T. Palayoor, R. M. Macklis, E. A. Bump and C. N. Coleman, Modulation of radiation-induced apoptosis and G2/M block in murine T-lymphoma cells. Radiat. Res. 141, 235-243 (1995).
G. C. Rice, J. Rosen, R. Weeks, J. Michnick, S. Bursten, J. A. Bianco and J. W. Singer, CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo. Shock 1, 254-266 (1994).
